The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the ...
Oct 6, 2012
0
0
Although COVID-19 has faded from the headlines, SARS-CoV-2—the coronavirus behind the pandemic—is still rampantly infecting people around the world. Public health officials fear as the virus continues to evolve, it will ...
Mar 13, 2024
0
53
A bioinformatic examination of HIV mutations documented in clinics could help guide the selection of antiretroviral therapies.
Sep 20, 2017
0
2
(Medical Xpress) -- Researchers at the University of California, San Diego, the Medical University of South Carolina, the University of Cincinnati, and American Life Science Pharmaceuticals of San Diego have validated the ...
Mar 7, 2012
0
0
Giving antiretroviral therapy (ART) immediately after diagnosis for a limited period of time is more beneficial than postponing treatment in young infants infected with HIV, slowing progression of the disease and delaying ...
Aug 21, 2013
0
0
Current or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse cardiovascular events (MACE) in people with HIV, according to an exploratory analysis from a large international ...
Jul 23, 2024
0
0
A finding by an international team of plant biologists could be important in research into Alzheimer's and other age-related diseases.The study is published this week in the prestigious journal Proceedings of the National ...
Sep 23, 2013
0
0
(HealthDay)—For untreated patients with hepatitis C virus (HCV), treatment with an oral nucleotide inhibitor of HCV polymerase, sofosbuvir, plus ribavirin seems effective for genotypes 1, 2, and 3; and the HCV NS3 protease ...
Jan 3, 2013
0
0
Nineteen months into the pandemic, the need for antiviral drugs targeted against COVID-19 is clear, given the global persistence of the virus, its ability to rapidly mutate into new variants and the possibility that it could ...
Oct 22, 2021
0
14
A research team at the Greenwood Genetic Center (GGC) has successfully used small molecules to restore normal heart and valve development in an animal model for Mucolipidosis II (ML II), a rare genetic disorder. Progressive ...
Oct 15, 2020
0
1
